Cardiovascular device co V-Wave raises $28m
The Israeli company is developing proprietary, minimally invasive interatrial shunt devices for treating patients with severe symptomatic heart failure and pulmonary arterial hypertension.
“Covid-19 has let digital health prove itself”
DLA Piper partner Danny Tobey, Tamar Tavory of Yigal Arnon & Co., and Igentify CEO Doron Behar came together in a webinar to discuss trends and opportunities in the health tech market.
Citron slams Nano-X Imaging as a fraud
The US activist short-seller researcher says that the Israeli company, currently worth $1.7 billion on Nasdaq, has invented fake customers and is a 'stock promotion' on the way to zero.
AI in the kitchen
Founder Gil Kerbs tells "Globes" about Newt and its personalized nutrition app, which provides motivation as well as menus.
Teva at the double
Good results, falling debt and Covid-19 have all contributed to the Israeli drugmaker's share price nearly doubling since March.